Impax Laboratories (IPXL)

Add to Watchlists
Create an Alert
32.28 -1.32  -3.93% NASDAQ May 4, 18:42 Delayed 2m USD
View Full Chart
IPXL Price Chart
View All Events

IPXL Events

Date Type Description
05/10/2016 08:30 EDT Misc Impax Laboratories Inc First Quarter Earnings Results in 2016
05/10/2016 Earnings Impax Laboratories Inc First Quarter Earnings Results in 2016 Release
03/07/2016 10:25 EST Misc Raymond James 37th Annual Institutional Investors Conference
02/22/2016 08:30 EST Misc Impax Laboratories Inc Fourth Quarter Earnings Conference Call in 2015
02/22/2016 Earnings Impax Laboratories Inc Fourth Quarter Earnings in 2015 Release
11/09/2015 08:30 EST Misc Impax Laboratories Inc Third Quarter Earnings Conference Call in 2015
11/09/2015 Earnings Impax Laboratories Inc Third Quarter Earnings in 2015 Release
08/10/2015 08:30 EDT Misc Impax Laboratories Inc Second Quarter Earnings Conference Call in 2015
08/10/2015 Earnings Impax Laboratories Inc Second Quarter Earnings in 2015 Release
05/11/2015 16:30 EDT Misc Impax Laboratories Inc First Quarter Earnings Conference Call in 2015
View All Performance Charts

IPXL Total Returns Comparison

Advertisement

One Page Reports

Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • URL: http://www.impaxlabs.com
  • Investor Relations URL: http://investors.impaxlabs.com/Investor-Relations/default.aspx
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: May 10, 2016
  • NAICS Name: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry Name: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: Impax Laboratories Inc is a technology-based, specialty pharmaceutical company. It is engaged in the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development.

IPXL Comparables

Edit

IPXL Excel Add-In Codes

  • Name: =YCI("IPXL","name")
  • Description: =YCI("IPXL","description")
  • Sector: =YCI("IPXL","sector")
  • Industry: =YCI("IPXL","industry")
  • Est. Current Fiscal Year End: =YCI("IPXL","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.